IMIM - Institut Hospital del Mar d'Investigacions Mèdiques IMIM - Institut Hospital del Mar d'Investigacions Mèdiques

News

03/12/2021 - Institutional news

1,880,000 to prepare reference materials to assess the quality of accredited anti-doping laboratories around the world

The Hospital del Mar Medical Research Institute (IMIM) has signed a five-year contract with the World Anti-Doping Agency (WADA, https://www.wada-ama.org/ ), within the framework of a tender of offers at an international level, worth € 1,880,000, for the preparation of reference materials for its external quality assessment program of laboratories (EQAS) accredited to carry out anti-doping control around the world (WADA's External Quality Assessment Scheme).

Dr. Oscar Pozo, group leader of the Applied Metabolomics Research Group of the Neurosciences Research Program at IMIM, will be responsible for the execution of the contract as of January 2022.

In order to participate in the bidding process, it was an essential requirement that the laboratory executing the project be accredited according to the ISO / IEC 17025: 2017 quality standard. This standard is the most demanding at the international level to demonstrate the competence of testing and calibration laboratories. IMIM was accredited for this standard this fall.

More news

© Institut Hospital del Mar
d'Investigacions Mèdiques
Legal Notice and Privacy Policy | Cookie Policy | Site Index | Accessibility | Find Us | Contact